Skip to content
Subscriber Only

China Turns to Precision Medicine in Fight Against Cancer

  • Push is part of a broader effort to dominate biotech globally
  • Genetic technologies attract funding from Chinese investors
Graphic representation of the DNA sequence
Photographer: Gio_tto/Getty Images/iStockphoto
Updated on

When Nisa Leung was pregnant with her first child in 2012, her doctor in Hong Kong offered her a choice. She could take a prenatal test that would require inserting a needle into her uterus, or pay $130 more for an exam that would draw a little blood from her arm.

Leung opted for the simpler and less risky test, which analyzed bits of the baby’s DNA that had made its way into her bloodstream. Then, Leung went on to do what she often does when she recognizes a good product: look around for companies to invest in.